Interleukin-1 receptor antagonist decreases severity of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/20 (2006.01) A61K 38/17 (2006.01) A61K 38/21 (2006.01) A61K 38/31 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01) C07K 14/54 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2179183

A method for treating acute pancreatitis comprising administering an effective amount of Interleukin-1 receptor antagonist (IL-1ra) or a pharmaceutically acceptable salt thereof to a person afflicted with that condition.

Un procédé qui permet de traiter la pancréatite aigue, consiste à administrer une dose efficace d'un antagoniste d'un récepteur de l'interleukine-1 (IL-1ra) ou un de ses sels pharmacologiquement acceptables à une personne souffrant de cette maladie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Interleukin-1 receptor antagonist decreases severity of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interleukin-1 receptor antagonist decreases severity of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-1 receptor antagonist decreases severity of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1930971

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.